Mitsui Chemicals stock gains 3.26 percent after product launch

Published on 10/05/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mitsui Chemicals stock was last at JPY 2,169.50 on October 5, 2026, after a 3.26 percent gain. Fiscal Q1 revenue reached JPY 460.046 billion.

Mitsui Chemicals, JP3888300005, Illustration mit AI erstellt.

Mitsui Chemicals stock (ISIN JP3888300005) was last at JPY 2,169.50 on the Tokyo Stock Exchange at 3:30 p.m. JST on October 5, 2026, up JPY 68.50 or 3.26 percent from the prior close. The move came as the company highlighted a new life-science product aimed at organoid-based drug research.

New culture plate targets drug research

Mitsui Chemicals said on October 5, 2026, that it launched InnoCell P-Type on October 1. The adherent culture plate combines oxygen-permeable material, surface treatment for cell adhesion, low autofluorescence and low drug adsorption.

The product is designed for three-dimensional cell models, including organoids, and for efficacy and toxicity screening. Company testing cited more uniform tissue formation in human induced pluripotent stem cell-derived cardiac organoids and high-sensitivity, low-variability evaluation of intestinal organoid-derived epithelial cells.

Fiscal Q1 brought higher earnings

Mitsui Chemicals reported fiscal Q1 revenue of JPY 460.046 billion, net income of JPY 32.093 billion and earnings per share of JPY 88.78 for the quarter reported on August 5, 2026, according to Investing.com. Revenue increased from JPY 450.043 billion in the preceding quarter, while net income rose from JPY 11.797 billion.

The company also set first-half fiscal 2026 guidance for revenue of JPY 957.0 billion, operating income of JPY 66.0 billion and net income of JPY 45.0 billion, figures reported by Simply Wall St. The guidance gives investors a second benchmark beyond the product launch: execution against the September 30 half-year period.

Consensus target stays above the quote

Investing.com lists a Buy consensus from 11 analysts, with five Buy ratings, four Holds and two Sells. The average 12-month target is JPY 2,505.50, with a high of JPY 3,600 and a low of JPY 1,880.

Using the October 5 quote of JPY 2,169.50, the average target lies 15.49 percent above the price. The stock remains 12.44 percent below its 52-week high of JPY 2,477.50, while its 52-week low is JPY 1,737.00.

Stock gains on October 5

Mitsui Chemicals stock was last at JPY 2,169.50 on the Tokyo Stock Exchange on October 5, 2026, with volume of 1,854,700 shares and a market capitalization of JPY 798.6 billion. The product launch, first-half guidance and valuation gap give the market several company-specific figures to track into the next results update.